Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
New drug combo aims to halt aggressive prostate cancer
Disease control OngoingThis study tests whether adding the drug darolutamide to surgery can delay the return or spread of high-risk prostate cancer. About 240 men will either have surgery alone or surgery plus darolutamide taken before and after the operation. The goal is to see if the combination keep…
Phase: PHASE2 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
Can a quick GP visit after cancer diagnosis improve care? new study investigates
Knowledge-focused OngoingThis study looks at whether it's possible for people diagnosed with solid tumors to have a follow-up visit with their general practitioner (GP) within 15 days of learning they have cancer. About 171 patients will take part, and researchers will track how many actually attend this…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 26, 2026 03:15 UTC
-
Cancer radiotherapy software study falls flat: no participants enrolled
Knowledge-focused TerminatedThis study was designed to see if automatic software could accurately outline tumors and healthy organs during radiation therapy for head and neck cancer. It planned to enroll adults with advanced head and neck cancer and compare manual and automatic contouring methods. However, …
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC